Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer.

Orgilmaa RegzedmaaYing LiYongwen LiHongbing ZhangJin WangHao GongYin YuanWeiting LiHongyu LiuJun Chen

Published in: OncoTargets and therapy (2019)

The expression of DLL3, CTLA-4 and MSTN was not correlated with patients' age, sex, smoking status, stage, and tumor metastasis. The fact that there was a higher expression of DLL3, CTLA-4, and MSTN in SCLC suggested that these molecules could be used as predictive biomarkers for SCLC.

Keyphrases

poor prognosis
small cell lung cancer
ejection fraction
newly diagnosed
binding protein
long non coding rna
risk factors
prognostic factors
brain metastases